ophthalmologytimes18h
European Commission grants marketing authorization to aflibercept biosimilar from Sandoz Group
Sandoz's approval of Afqlir highlights their commitment to affordable, effective treatment options for retinal diseases.
The Financial Express1d
European Commission grants approval to Sandoz’s biosimilar to treat retinal diseases
Afqlir is indicated to treat various retinal diseases, including neovascular age-related macular degeneration (nAMD) ...
Zebrafish experiment on China's space station sets new record
A closed aquatic ecosystem established on China space station proved to be successful as four zebrafish kept in it completed their life stages from g ...
PipelineReview.com1d
Sandoz receives European Commission approval for Afqlir® (aflibercept), further strengthening leading biosimilar portfolio
BASEL, Switzerland I November 15, 2024 I Sandoz (SIX:SDZ/OTCQX:SDZNY), the global leader in generic and biosimilar medicines, today announced that the ...
Le Lézard2d
WuXi Biologics Germany to Enhance Capabilities with New Prefilled Syringes Line
The new line, with its capability to handle multiple syringe sizes (1 ml, 2.25 ml ... at the Gerontological Society of America Annual Scientific Meeting 2024 Epirium Bio, Inc. (Epirium), a ...
medtechdive2d
Dean Kamen, insulin pump pioneer, wants to shake up diabetes tech
Kamen and Sequel Medtech CEO Alan Lotvin say they are offering greater precision in insulin delivery with new pump technology ...
Le Lézard3d
Poster Presentation at International mRNA Health Conference Showcases Clinical Evidence that PharmaJet® Delivery Systems Enable mRNA Vaccine Delivery
Evaluation of luciferase and prefusion-stability F protein from respiratory syncytial virus mRNA/LNPs in pre-clinical models using jet delivery compared to needle and syringe ... in mRNA technologies ...